SURMODICS (NASDAQ:SRDX)
22.92
-0 (-0%)
| SURMODICS (NASDAQ:SRDX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $22.92 | 52 Week High | $31.00 | ||
| Open | $22.60 | 52 Week Low | $15.96 | ||
| Day High | $23.07 | P/E | 10.66 | ||
| Day Low | $22.53 | EPS | $2.15 | ||
| Volume | 83,148 | ||||
| More SRDX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| NTRI | 3 | EMR | 2 |
| VRNM | 2 | FONR | 2 |
| VRNMD | 2 | ARRS | 2 |
| ICTG | 2 | WMT | 2 |
| MNKD | 2 | ACAD | 2 |
| ARP | 2 | PSTI | 2 |
Entities who have mentioned SRDX
- Citi | View Related Stories »
- Dividend | View Related Stories »
- Goldman Sachs | View Related Stories »
- Wachovia | View Related Stories »
- Morgan Stanley | View Related Stories »
- Crude Oil | View Related Stories »
- CL King | View Related Stories »
- Jefferies & Co | View Related Stories »
- UBS | View Related Stories »
- After-Hours Movers | View Related Stories »
- Sidoti & Company | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Stock Buyback | View Related Stories »
- ADP Employment Report | View Related Stories »
- Federal Open Market Committee | View Related Stories »
- Trading Radar | View Related Stories »
- Layoffs | View Related Stories »
- Vanguard | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- SMH Capital | View Related Stories »
View All Major News StreetInsider.com Major News for SRDX
- SurModics (SRDX) Misses Q4 EPS by 4c
- SurModics, Inc. (SRDX) Enters Agreement with Genetech and Roche to Develop and Commercialize Lucentis
- SurModics (SRDX) Reports Q2 EPS In-Line
View All ReportsStreetInsider.com Reports on SRDX
- SurModics (SRDX) Misses Q4 EPS by 4c
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Barrington Research Downgrades SurModics (SRDX) to Market Perform
- Unusual 11 Mid-Day Movers 10/06: FONR, ICTG, ACAD, AVCT Higher; MNKD, VRNMD, ARP, PPD Lower
- SurModics (SRDX) Surges On License Deal With Roche and Genentech
View All Press ReleasesCompany Press Releases on SRDX
- SurModics Reports Fourth Quarter and Fiscal Year 2009 Results
- SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment
- SurModics to Webcast Fourth Quarter and Fiscal Year 2009 Earnings Conference Call November 4
- SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
StreetInsider Reports on SRDX by Category
View All BlogsBlogs on SRDX
- Developments for Parkinson's Disease Ignite Investor Enthusiasm
- SurModics, Inc.Q4 2009 Earnings Call Transcript
- M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets
- SurModics Q2 2009 Earnings Transcript
- Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
View All FilingsSEC Filings on SRDX
- Form 4 SURMODICS INC For: Nov 17 Filed by: Anderson Aron B
- Form 4 SURMODICS INC For: Nov 16 Filed by: Phillips Bryan K
- Form 4 SURMODICS INC For: Nov 15 Filed by: ANKENY PHILIP D
- Form 4 SURMODICS INC For: Nov 15 Filed by: OLSON CHARLES W
- Form 4 SURMODICS INC For: Nov 15 Filed by: BARCLAY BRUCE
Comments on recent SRDX articles
Comments on SRDX
No comments are currently available.
on Jan 29, 2009
at 01:56 PM downgrade this is long overdue, it should be a underperform from what I know
Article: CL King Downgrades SurModics (SRDX) to Neutral